Trademark: 79278878
Word
VYNCEDE
Status
Registered
Status Code
700
Status Date
Tuesday, June 23, 2020
Serial Number
79278878
Registration Number
6082595
Registration Date
Tuesday, June 23, 2020
Mark Type
4000
Filing Date
Wednesday, November 27, 2019
Published for Opposition
Tuesday, April 7, 2020

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Oct 2, 2020
Notification Processed By Ib
Sep 6, 2020
Final Disposition Notice Sent To Ib
Aug 28, 2020
Final Disposition Processed
Jul 23, 2020
Grant Of Protection Created, To Be Sent To Ib
Jun 23, 2020
Registered-Principal Register
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 18, 2020
Teas Change Of Correspondence Received
Mar 18, 2020
Teas Change Of Domestic Representatives Address
Mar 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 18, 2020
Teas Change Of Owner Address Received
Mar 18, 2020
Notice Of Publication
Feb 28, 2020
Approved For Pub - Principal Register
Feb 27, 2020
Assigned To Examiner
Feb 25, 2020
Application Filing Receipt Mailed
Feb 20, 2020
New Application Office Supplied Data Entered In Tram
Feb 18, 2020
Limitation From Original Application Entered
Feb 13, 2020
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24